287 related articles for article (PubMed ID: 22676968)
1. Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico.
Davidson PJ; Lozada R; Rosen PC; Macias A; Gallardo M; Pollini RA
Int J Drug Policy; 2012 Jul; 23(4):286-94. PubMed ID: 22676968
[TBL] [Abstract][Full Text] [Related]
2. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
4. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A; Rhodes T; Platt L
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.
Lewis CF; Rivera AV; Crawford ND; DeCuir J; Amesty S
Drug Alcohol Depend; 2015 Aug; 153():72-7. PubMed ID: 26118831
[TBL] [Abstract][Full Text] [Related]
6. Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.
Yang Y; Latkin C; Luan R; Yang C
Int J Drug Policy; 2016 Jan; 27():113-20. PubMed ID: 26123897
[TBL] [Abstract][Full Text] [Related]
7. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
8. Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.
Ibragimov U; Cooper HL; Haardörfer R; Dunkle KL; Zule WA; Wong FY
Harm Reduct J; 2017 Sep; 14(1):64. PubMed ID: 28915888
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
[TBL] [Abstract][Full Text] [Related]
10. A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics.
Fadanelli M; Cooper HLF; Freeman PR; Ballard AM; Ibragimov U; Young AM
Harm Reduct J; 2022 Jan; 19(1):1. PubMed ID: 34996466
[TBL] [Abstract][Full Text] [Related]
11. Over-the-counter but out of reach: a pharmacy-based survey of OTC syringe sales in Tijuana, Mexico.
Pollini RA; Gallardo M; Ruiz S; Case P; Zaller N; Lozada R
J Health Care Poor Underserved; 2014 May; 25(2):637-51. PubMed ID: 24858873
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis.
Cepeda JA; Burgos JL; Kahn JG; Padilla R; Meza Martinez PE; Segovia LA; Gaines T; Abramovitz D; Rangel G; Magis-Rodriguez C; Vickerman P; Strathdee SA; Martin NK
BMJ Open; 2019 Jan; 9(1):e026298. PubMed ID: 30700490
[TBL] [Abstract][Full Text] [Related]
13. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey.
Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY
Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505
[TBL] [Abstract][Full Text] [Related]
15. Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review.
Gionfriddo MR; Owens KM; Leist SE; Schrum LT; Covvey JR
J Am Pharm Assoc (2003); 2023; 63(5):1472-1489.e3. PubMed ID: 37429389
[TBL] [Abstract][Full Text] [Related]
16. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
Pollini RA
J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.
Yang Y; Latkin CA; Luan R; Yang C
BMC Public Health; 2015 Sep; 15():885. PubMed ID: 26370245
[TBL] [Abstract][Full Text] [Related]
18. 'It's just basically a box full of disease'-navigating sterile syringe scarcity in a rural New England state.
Pollini RA; Paquette CE; Slocum S; LeMire D
Addiction; 2021 Jan; 116(1):107-115. PubMed ID: 32415706
[TBL] [Abstract][Full Text] [Related]
19. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
[TBL] [Abstract][Full Text] [Related]
20. Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019.
Marotta PL; Stringer K; Beletsky L; West BS; Goddard-Eckrich D; Gilbert L; Hunt T; Wu E; El-Bassel N
Harm Reduct J; 2021 Nov; 18(1):115. PubMed ID: 34789270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
